Search

everythinglearnresearchcommunity

for

Search:↓

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Fludalanine failed as an effective oral antibiotic despite efforts.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Fisetin, found in fruits and vegetables, may help treat various health conditions like inflammation, diabetes, heart issues, cancer, and hair loss.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.